Last Updated: November 12, 2026

Details for Patent: RE50218

Name: Drug Patent Intelligence for US Patent RE50218
Creator: DrugPatentWatch
License: https://www.drugpatentwatch.com/terms.php

« Back to Dashboard

Which drugs does patent RE50218 protect, and when does it expire?

Patent RE50218 protects BROMSITE and is included in one NDA.

This patent has six patent family members in six countries.

Summary for Patent: RE50218

Title:	Non-steroidal anti-inflammatory ophthalmic compositions
Abstract:	The disclosure provides compositions and systems for topical ophthalmic application, which include an aqueous mixture of bromfenac and flowable mucoadhesive polymer, for treating inflammation and inflammatory conditions of the eye.
Inventor(s):	Kamran Hosseini, Lyle Bowman, Erwin C. Si, Stephen Pham
Assignee:	Sun Pharmaceutical Industries Ltd
Application Number:	US17/726,665
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent RE50218
Patent Claim Types: see list of patent claims	Use; Composition;

Drugs Protected by US Patent RE50218

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sun Pharm	BROMSITE	bromfenac sodium	SOLUTION/DROPS;OPHTHALMIC	206911-001	Apr 8, 2016	AB	RX	Yes	Yes	RE50218	⤷ Start Trial	Y			TREATMENT OF POSTOPERATIVE INFLAMMATION AND PREVENTION OF OCULAR PAIN IN PATIENTS UNDERGOING CATARACT SURGERY	⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Patented / Exclusive Use	>Submissiondate

International Family Members for US Patent RE50218

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Canada	2753947	⤷ Start Trial
Denmark	2403493	⤷ Start Trial
European Patent Office	2403493	⤷ Start Trial
Spain	2586064	⤷ Start Trial
Portugal	2403493	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration	>Supplementary Protection Certificate	>SPC Country	>SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.